-
Who we are
Who we are
We are a biotechnology company committed to helping address serious infectious diseases globally through the discovery and development of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
What we do
What we do
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
COVID-19 UPDATESNovavax has demonstrated its ability to quickly develop viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Blog
Blog
Novavax is committed to accelerating the development of new and promising vaccines and sharing information based on years of study and experience.
33rd Annual J.P. Morgan Healthcare Conference
Wednesday, January 14, 2015
11:30am - 11:59pm PST
Presenter: Stanley Erck
Location
San Francisco, CA
United States
Get notifications for investor updates
Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.
Investor inquiries
Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at [email protected]
Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.
![Graph icon](/sites/default/files/images/Investors-Abstract.png)